108 related articles for article (PubMed ID: 31389380)
1. WT1 in astrocytomas: Comprehensive evaluation of immunohistochemical expression and its potential utility in different histological grades.
Manocha A; Jain S
Indian J Cancer; 2019; 56(3):197-201. PubMed ID: 31389380
[TBL] [Abstract][Full Text] [Related]
2. WT1 Clone 6F-H2 Cytoplasmic Expression Differentiates Astrocytic Tumors from Astrogliosis and Associates with Tumor Grade, Histopathology, IDH1 Status, Apoptotic and Proliferative Indices: A Tissue Microarray Study.
Abd El-Hafez A; Ismail Hany HSED
Asian Pac J Cancer Prev; 2020 Aug; 21(8):2403-2413. PubMed ID: 32856872
[TBL] [Abstract][Full Text] [Related]
3. WT1 expression distinguishes astrocytic tumor cells from normal and reactive astrocytes.
Schittenhelm J; Mittelbronn M; Nguyen TD; Meyermann R; Beschorner R
Brain Pathol; 2008 Jul; 18(3):344-53. PubMed ID: 18371184
[TBL] [Abstract][Full Text] [Related]
4. WT1 expression increases with malignancy and indicates unfavourable outcome in astrocytoma.
Rauscher J; Beschorner R; Gierke M; Bisdas S; Braun C; Ebner FH; Schittenhelm J
J Clin Pathol; 2014 Jul; 67(7):556-61. PubMed ID: 24607494
[TBL] [Abstract][Full Text] [Related]
5. High-grade astrocytomas show increased Nestin and Wilms's tumor gene (WT1) protein expression.
Rushing EJ; Sandberg GD; Horkayne-Szakaly I
Int J Surg Pathol; 2010 Aug; 18(4):255-9. PubMed ID: 19578047
[TBL] [Abstract][Full Text] [Related]
6. PROX1 is a novel pathway-specific prognostic biomarker for high-grade astrocytomas; results from independent glioblastoma cohorts stratified by age and IDH mutation status.
Roodakker KR; Elsir T; Edqvist PD; Hägerstrand D; Carlson J; Lysiak M; Henriksson R; Pontén F; Rosell J; Söderkvist P; Stupp R; Tchougounova E; Nistér M; Malmström A; Smits A
Oncotarget; 2016 Nov; 7(45):72431-72442. PubMed ID: 27626492
[TBL] [Abstract][Full Text] [Related]
7. Nuclear karyopherin a2: a novel biomarker for infiltrative astrocytomas.
Gousias K; Becker AJ; Simon M; Niehusmann P
J Neurooncol; 2012 Sep; 109(3):545-53. PubMed ID: 22772608
[TBL] [Abstract][Full Text] [Related]
8. Apparent diffusion coefficient in the evaluation of cerebral gliomas malignancy.
Ignjatović J; Stojanov D; Zivković V; Ljubisavljević S; Stojanović N; Stefanović I; Benedeto-Stojanović D; Ignjatović N; Petrović S; Aracki-Trenkić A; Radovanović Z; Lazović L
Vojnosanit Pregl; 2015 Oct; 72(10):870-5. PubMed ID: 26665552
[TBL] [Abstract][Full Text] [Related]
9. Patients with IDH1 wild type anaplastic astrocytomas exhibit worse prognosis than IDH1-mutated glioblastomas, and IDH1 mutation status accounts for the unfavorable prognostic effect of higher age: implications for classification of gliomas.
Hartmann C; Hentschel B; Wick W; Capper D; Felsberg J; Simon M; Westphal M; Schackert G; Meyermann R; Pietsch T; Reifenberger G; Weller M; Loeffler M; von Deimling A
Acta Neuropathol; 2010 Dec; 120(6):707-18. PubMed ID: 21088844
[TBL] [Abstract][Full Text] [Related]
10. Manganese superoxide dismutase (MnSOD) is a malignant astrocytoma specific biomarker and associated with adverse prognosis in p53 expressing glioblastoma.
Shwetha SD; Shastry AH; Arivazhagan A; Santosh V
Pathol Res Pract; 2016 Jan; 212(1):17-23. PubMed ID: 26616112
[TBL] [Abstract][Full Text] [Related]
11. peIF4E as an independent prognostic factor and a potential therapeutic target in diffuse infiltrating astrocytomas.
Martínez-Sáez E; Peg V; Ortega-Aznar A; Martínez-Ricarte F; Camacho J; Hernández-Losa J; Ferreres Piñas JC; Ramón Y Cajal S
Cancer Med; 2016 Sep; 5(9):2501-12. PubMed ID: 27440383
[TBL] [Abstract][Full Text] [Related]
12. Comparative transcriptomics reveals similarities and differences between astrocytoma grades.
Seifert M; Garbe M; Friedrich B; Mittelbronn M; Klink B
BMC Cancer; 2015 Dec; 15():952. PubMed ID: 26673168
[TBL] [Abstract][Full Text] [Related]
13. Measurable residual disease monitoring using Wilms tumor gene 1 expression in childhood acute myeloid leukemia based on child-specific reference values.
Løvvik Juul-Dam K; Guldborg Nyvold C; Vålerhaugen H; Zeller B; Lausen B; Hasle H; Beier Ommen H
Pediatr Blood Cancer; 2019 Jun; 66(6):e27671. PubMed ID: 30900388
[TBL] [Abstract][Full Text] [Related]
14. Expression of the small heat shock protein (hsp) 27 in human astrocytomas correlates with histologic grades and tumor growth fractions.
Khalid H; Tsutsumi K; Yamashita H; Kishikawa M; Yasunaga A; Shibata S
Cell Mol Neurobiol; 1995 Apr; 15(2):257-68. PubMed ID: 8590455
[TBL] [Abstract][Full Text] [Related]
15. High prognostic value of pre-allogeneic stem cell transplantation minimal residual disease detection by WT1 gene expression in AML transplanted in cytologic complete remission.
Candoni A; De Marchi F; Zannier ME; Lazzarotto D; Filì C; Dubbini MV; Rabassi N; Toffoletti E; Lau BW; Fanin R
Leuk Res; 2017 Dec; 63():22-27. PubMed ID: 29096332
[TBL] [Abstract][Full Text] [Related]
16. Tissue thioredoxin reductase-1 expression in astrocytomas of different grades.
Esen H; Erdi F; Kaya B; Feyzioglu B; Keskin F; Demir LS
J Neurooncol; 2015 Feb; 121(3):451-8. PubMed ID: 25391969
[TBL] [Abstract][Full Text] [Related]
17. Mitosin and pHH3 predict poorer survival in astrocytomas WHO grades II and III.
Varughese RK; Lind-Landström T; Habberstad AH; Salvesen Ø; Haug CS; Sundstrøm S; Torp SH
J Clin Pathol; 2016 Jan; 69(1):26-34. PubMed ID: 26188054
[TBL] [Abstract][Full Text] [Related]
18. Evidence for a clinically distinct new subtype of grade II astrocytomas in patients with long-term epilepsy.
Schramm J; Luyken C; Urbach H; Fimmers R; Blümcke I
Neurosurgery; 2004 Aug; 55(2):340-7; discussion 347-8. PubMed ID: 15271240
[TBL] [Abstract][Full Text] [Related]
19. Grading of astrocytomas. A simple and reproducible method.
Daumas-Duport C; Scheithauer B; O'Fallon J; Kelly P
Cancer; 1988 Nov; 62(10):2152-65. PubMed ID: 3179928
[TBL] [Abstract][Full Text] [Related]
20. Survivin, caspase-3 and MIB-1 expression in astrocytic tumors of various grades.
Lebelt A; Rutkowski R; Och W; Jaczun K; Dziemiańczyk-Pakieła D; Milewski R; Mariak Z; Reszeć J
Adv Med Sci; 2016 Sep; 61(2):237-243. PubMed ID: 26995334
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
